I.J. McGilveray

2.0k total citations · 1 hit paper
70 papers, 1.6k citations indexed

About

I.J. McGilveray is a scholar working on Analytical Chemistry, Pharmacology and Spectroscopy. According to data from OpenAlex, I.J. McGilveray has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Analytical Chemistry, 24 papers in Pharmacology and 20 papers in Spectroscopy. Recurrent topics in I.J. McGilveray's work include Analytical Methods in Pharmaceuticals (30 papers), Analytical Chemistry and Chromatography (19 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). I.J. McGilveray is often cited by papers focused on Analytical Methods in Pharmaceuticals (30 papers), Analytical Chemistry and Chromatography (19 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). I.J. McGilveray collaborates with scholars based in Canada, United States and Germany. I.J. McGilveray's co-authors include K.K. Midha, Thomas Layloff, Jerome P. Skelly, R.D. McDowall, Vinod P. Shah, C.T. Viswanathan, Avraham Yacobi, C. E. Cook, J.K. Cooper and S. Sved and has published in prestigious journals such as Journal of Chromatography A, Clinical Chemistry and Journal of Pharmaceutical Sciences.

In The Last Decade

I.J. McGilveray

69 papers receiving 1.5k citations

Hit Papers

Analytical methods validation: Bioavailability, bioequiva... 1991 2026 2002 2014 1991 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I.J. McGilveray Canada 21 388 381 318 317 240 70 1.6k
Shrikant V. Dighe United States 11 372 1.0× 336 0.9× 317 1.0× 402 1.3× 194 0.8× 20 1.7k
B Widdop United Kingdom 19 521 1.3× 413 1.1× 393 1.2× 363 1.1× 408 1.7× 49 2.4k
Kenneth A. Pittman United States 17 352 0.9× 520 1.4× 284 0.9× 478 1.5× 201 0.8× 32 2.2k
Rabindra Patnaik United States 8 250 0.6× 368 1.0× 209 0.7× 397 1.3× 215 0.9× 11 1.8k
J.C.K. Loo Canada 13 270 0.7× 463 1.2× 212 0.7× 242 0.8× 236 1.0× 25 1.4k
Francis L. S. Tse Japan 28 239 0.6× 496 1.3× 486 1.5× 721 2.3× 265 1.1× 110 2.7k
Gordon McKay Canada 17 266 0.7× 486 1.3× 266 0.8× 436 1.4× 323 1.3× 23 2.1k
James D. Hulse United States 18 311 0.8× 410 1.1× 314 1.0× 521 1.6× 221 0.9× 31 2.2k
Alfred Tonelli United States 12 261 0.7× 434 1.1× 218 0.7× 477 1.5× 251 1.0× 25 2.0k
W.F. Bayne United States 20 237 0.6× 281 0.7× 222 0.7× 427 1.3× 144 0.6× 63 1.3k

Countries citing papers authored by I.J. McGilveray

Since Specialization
Citations

This map shows the geographic impact of I.J. McGilveray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.J. McGilveray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.J. McGilveray more than expected).

Fields of papers citing papers by I.J. McGilveray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.J. McGilveray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.J. McGilveray. The network helps show where I.J. McGilveray may publish in the future.

Co-authorship network of co-authors of I.J. McGilveray

This figure shows the co-authorship network connecting the top 25 collaborators of I.J. McGilveray. A scholar is included among the top collaborators of I.J. McGilveray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.J. McGilveray. I.J. McGilveray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, AJ, et al.. (2005). Guidelines for the Use of Cannabinoid Compounds in Chronic Pain. Pain Research and Management. 10(A). 44A–6A. 23 indexed citations
2.
Qureshi, S. A. & I.J. McGilveray. (1998). Assessment of Pharmaceutical Quality of Furosemide Tablets from Multinational Markets. Drug Development and Industrial Pharmacy. 24(11). 995–1005. 20 indexed citations
3.
Qureshi, S. A., Gilles Caillé, R. Brien, et al.. (1994). Application of Flow-Through Dissolution Method for the Evaluation of Oral Formulations of Nifedipine. Drug Development and Industrial Pharmacy. 20(11). 1869–1882. 26 indexed citations
4.
Gallicano, Keith, et al.. (1993). Pharmacokinetics of zidovudine after the initial single dose and during chronic‐dose therapy in HIV‐infected patients.. British Journal of Clinical Pharmacology. 36(2). 128–131. 11 indexed citations
5.
Baxter, Alan D., et al.. (1991). A dose-response study of nalbuphine for post-thoracotomy epidural analgesia. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 38(2). 175–182. 16 indexed citations
6.
Foster, Brian C., David L. Wilson, & I.J. McGilveray. (1990). Interaction of ethanol, quinidine, and sparteine with the metabolism of nifedipine by cunninghamella echinulata. Biopharmaceutics & Drug Disposition. 11(8). 735–738. 4 indexed citations
7.
O’Leary, Gerald, et al.. (1990). Intranasal nifedipine for post-bypass hypertension--hemodynamics and pharmacokinetics.. PubMed. 37(4 Pt 2). S144–S144. 2 indexed citations
8.
Foster, Brian C., Harpal S. Buttar, S. A. Qureshi, & I.J. McGilveray. (1989). Propranolol Metabolism byCunninghamella Bainieri. Xenobiotica. 19(5). 539–546. 14 indexed citations
9.
Foster, Brian C., David L. Wilson, & I.J. McGilveray. (1989). Effect of Sparteine and Quinidine on the Metabolism of Methoxyphenamine byCunninghamella Bainieri. Xenobiotica. 19(4). 445–452. 17 indexed citations
10.
Wilson, David L., et al.. (1987). HPLC Determination of Methylphenidate in Human Plasma. Journal of Liquid Chromatography. 10(10). 2257–2264. 8 indexed citations
11.
Wilson, David L., et al.. (1986). Rapid high-performance liquid chromatographic determination of ibuprofen in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 377. 410–414. 21 indexed citations
12.
Midha, K.K., et al.. (1981). High-performance Liquid Chromatographic Assay for Nanogram Determination of Chlorpromazine and its Comparison with a Radioimmunoassay. Journal of Pharmaceutical Sciences. 70(9). 1043–1046. 30 indexed citations
13.
Loo, J.C.K., et al.. (1981). Pharmacokinetic evaluation of betameth asone and its water soluble phosphate ester in humans. Biopharmaceutics & Drug Disposition. 2(3). 265–272. 13 indexed citations
14.
Loo, J.C.K., et al.. (1981). The Estimation of Serum Digoxin by Combined HPLC Separation and Radioimmunological Assay. Journal of Liquid Chromatography. 4(5). 879–886. 11 indexed citations
15.
Midha, K.K., et al.. (1977). High performance liquid chromatographic and mass spectrometric identification of dimethylxanthine metabolites of caffeine in human plasma. Journal of Mass Spectrometry. 4(3). 172–177. 37 indexed citations
16.
Midha, K.K., I.J. McGilveray, & David L. Wilson. (1976). Sensitive GLC Procedure for Simultaneous Determination of Phenytoin and its Major Metabolite from Plasma Following Single Doses of Phenytoin. Journal of Pharmaceutical Sciences. 65(8). 1240–1243. 11 indexed citations
17.
McGilveray, I.J., et al.. (1975). Effect of an Antacid on Absorption of Digoxin in Dogs. Journal of Pharmaceutical Sciences. 64(10). 1727–1728. 2 indexed citations
18.
McGilveray, I.J., Walter Tostowaryk, I. McMillan, & Edward G Lovering. (1975). Comparative Bioavailabilities from Truncated Blood Level Curves. Journal of Pharmaceutical Sciences. 64(9). 1521–1524. 35 indexed citations
19.
Midha, K.K., et al.. (1974). GLC Determination of γ-Hydroxyphenylbutazone in Plasma. Journal of Pharmaceutical Sciences. 63(11). 1751–1754. 4 indexed citations
20.
McGilveray, I.J., et al.. (1971). A study of bioavailabilities and dissolution rates of commercial tablets of nitrofurantoin. Journal of Pharmacy and Pharmacology. 23(Supplement_1). 246S–246S. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026